Indeed, several studies have demonstrated a relatively pronounced HER-2/neu overexpression on PC, 90%, compared to DCIS or invasive BC expression without MPD, 50% and 20%, respectively [18,19]. This evidence concerns the gene ERBB2 and breast cancer.